AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools ...
In a turbulent market environment, SLRN stock has reached a 52-week low, trading at $1.85. According to InvestingPro data, the company maintains a strong liquidity position with a current ratio of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback